CHRNA5 Variant Predicts Smoking Cessation in Patients With Acute Myocardial Infarction

Por Chen, Li-Shiun, Bach, Richard G., Lenzini, Petra A., Spertus, John A., Bierut, Laura Jean, Cresci, Sharon
Publicado em 2014

Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction

Por Depta, Jeremiah P., Lenzini, Petra A., Lanfear, David E., Wang, Tracy Y., Spertus, John A., Bach, Richard G., Cresci, Sharon
Publicado no Pharmacogenomics J (2014)

Cytochrome P450 Gene Variants, Race, and Mortality Among Clopidogrel Treated Patients Following Acute Myocardial Infarction

Por Cresci, Sharon, Depta, Jeremiah P., Lenzini, Petra A., Li, Allie Y., Lanfear, David E., Province, Michael A., Spertus, John A., Bach, Richard G.
Publicado em 2014

Adrenergic-pathway Gene Variants Influence β-Blocker-related Outcomes after Acute Coronary Syndrome in a Race-specific Manner

Por Cresci, Sharon, Dorn, Gerald W., Jones, Philip G., Beitelshees, Amber L., Li, Allie Y., Lenzini, Petra A., Province, Michael A., Spertus, John A., Lanfear, David E.
Publicado em 2012

Utility of a Genetic Risk Score to Predict Recurrent Cardiovascular Events 1 Year After an Acute Coronary Syndrome: A Pooled Analysis of the RISCA, PRAXY, and TRIUMPH Cohorts

Por Labos, Christopher, Martinez, Sara C., Leo Wang, Rui Hao, Lenzini, Petra A., Pilote, Louise, Bogaty, Peter, Brophy, James M., Engert, James C., Cresci, Sharon, Thanassoulis, George
Publicado no Atherosclerosis (2015)

Genetic-based dosing in orthopedic patients beginning warfarin therapy

Por Millican, Eric A., Lenzini, Petra A., Milligan, Paul E., Grosso, Leonard, Eby, Charles, Deych, Elena, Grice, Gloria, Clohisy, John C., Barrack, Robert L., Burnett, R. Stephen J., Voora, Deepak, Gatchel, Susan, Tiemeier, Amy, Gage, Brian F.
Publicado em 2007

Laboratory and Clinical Outcomes of Pharmacogenetic vs. Clinical Protocols for Warfarin Initiation in Orthopedic Patients

Por Lenzini, Petra A., Grice, Gloria R., Milligan, Paul E., Dowd, Mary Beth, Subherwal, Sumeet, Deych, Elena, Eby, Charles S., King, Cristi R., Porche-Sorbet, Rhonda M., Murphy, Claire V., Marchand, Renee, Millican, Eric A., Barrack, Robert L., Clohisy, John C., Kronquist, Kathryn, Gatchel, Susan K., Gage, Brian F.
Publicado em 2008

Pharmacogenetic Warfarin Dose Refinements Remain Significantly Influenced by Genetic Factors after One Week of Therapy

Por Horne, Benjamin D., Lenzini, Petra A., Wadelius, Mia, Jorgensen, Andrea L., Kimmel, Stephen E., Ridker, Paul M., Eriksson, Niclas, Anderson, Jeffrey L., Pirmohamed, Munir, Limdi, Nita A., Pendleton, Robert C., McMillin, Gwendolyn A., Burmester, James K., Kurnik, Daniel, Stein, C. Michael, Caldwell, Michael D., Eby, Charles S., Rane, Anders, Lindh, Jonatan D., Shin, Jae-Gook, Kim, Ho-Sook, Angchaisuksiri, Pantep, Glynn, Robert J., Kronquist, Kathryn E., Carlquist, John F., Grice, Gloria R., Barrack, Robert L., Li, Juan, Gage, Brian F.
Publicado em 2011